Loading stock data…
Loading stock data…
US$50.92
Get one email when ELVN crosses your level. Checked every 15 minutes during market hours.
▼ -2.24 (-4.21%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
59.2
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
2.47
Bearish momentumMACD below its signal line (2.56).
50-day average
43.88
Price aboveShort-term trend reference.
200-day average
30.99
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Enliven Therapeutics Inc. is a biotechnology company dedicated to the development of novel therapeutic solutions targeting specific diseases. The primary focus of the company lies in advancing the field of precision medicine, which aims to tailor medical treatment to the individual characteristics of each patient, enhancing treatment efficacy and minimizing side effects. Enliven Therapeutics Inc. is actively engaged in researching and developing targeted therapies that address unmet medical need…
www.enliventherapeutics.com7 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-07-01)
6 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (17 analysts, 2026-06-01)
5 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-05-01)
5 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -0.41 | -0.38 | ✓ Beat |
| 2026-04-24 | 1.56 | 1.59 | ✓ Beat |
| 2026-03-03 | -0.47 | -0.48 | ✗ Miss |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-28 | 2.94 | 2.57 | ✗ Miss |
| 2025-11-12 | -0.46 | -0.32 | ✓ Beat |
| 2025-10-27 | 0.54 | 0.54 | ✓ Beat |
| 2025-09-10 | -0.16 | -0.31 | ✗ Miss |
Companies in the same industry, via Finnhub